The Tennis Elbow Treatment Market is expected to reach US$ 1,028.86 Million by 2034 from US$ 705.24 Million in 2025, registering a CAGR of 4.83% during 2026–2034. The market is expanding as healthcare providers, orthopedic specialists, physiotherapy clinics, and patients increasingly seek effective solutions for lateral epicondylitis, commonly known as tennis elbow. Demand is supported by the rising incidence of repetitive-strain injuries, sports-related injuries, and musculoskeletal disorders, alongside growing awareness of non-surgical treatment options.
Tennis elbow is not limited to tennis players. Repetitive wrist and forearm movements can affect manual workers, athletes, office workers, and other groups exposed to recurring physical stress. Industry research identifies repetitive motion, sports participation, and occupational activities as important contributors to demand for treatment.
What is driving the market?
The rising prevalence of lateral epicondylitis, increasing participation in sports and physical activities, occupational repetitive-strain injuries, and growing adoption of non-invasive therapies are key drivers of the tennis elbow treatment market. The condition affects approximately 1%–3% of the population annually, with risk associated with repetitive movements and activities involving high physical loads.
Treatment demand is also being supported by the broader focus on musculoskeletal health and early management. Patients may receive a combination of activity modification, physical therapy, braces, medications, injections, or other interventions depending on the severity and duration of symptoms.
Non-surgical treatment remains an important part of the treatment landscape. Physical therapy, exercise-based rehabilitation, bracing, medications, and other conservative approaches are commonly used before surgical intervention. A UK clinical-practice survey found that 81% of respondents recommended exercise-based physiotherapy as the first-line intervention for chronic tennis elbow.
Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00040052
Which region leads?
North America represents a leading regional market for tennis elbow treatment, supported by established orthopedic and sports-medicine infrastructure, high healthcare expenditure, specialist availability, and growing demand for advanced musculoskeletal treatment. One recent market estimate places North America’s share at 38.4% in 2025.
The region’s established network of hospitals, orthopedic centers, rehabilitation clinics, and physiotherapy providers supports the adoption of both conservative and procedural treatment approaches. The presence of major medical-device companies also contributes to product development in orthopedic supports, rehabilitation technologies, and surgical systems.
Asia Pacific is emerging as an important growth market, supported by expanding healthcare infrastructure, increasing participation in sports and physical activities, growing awareness of musculoskeletal disorders, and improving access to orthopedic and rehabilitation services. Industry forecasts identify Asia Pacific as the fastest-growing regional market in some current estimates.
China, Japan, and India provide opportunities as healthcare facilities expand their orthopedic and physiotherapy capabilities. Increasing urban employment and repetitive occupational activities can also contribute to demand for treatment and rehabilitation services.
Europe represents another significant market, supported by established healthcare systems, sports medicine capabilities, and increasing attention to non-invasive management of musculoskeletal conditions. Latin America and the Middle East & Africa offer additional opportunities as healthcare infrastructure and access to specialized orthopedic services improve.
Which segment leads?
Non-surgical therapies represent a major component of the tennis elbow treatment market, reflecting the emphasis on conservative management before surgical intervention. Physical therapy, medications, braces, activity modification, and other non-invasive approaches are widely used in the treatment pathway.
Physical therapy is particularly important because rehabilitation focuses on restoring strength and function while addressing the mechanical factors associated with tendon overload. Market research also identifies physical therapy as a leading treatment segment in the broader tennis elbow treatment landscape.
Braces and supports are another important product category. Counterforce braces and related orthopedic supports can be used to reduce strain on the affected area and support rehabilitation. Increasing product innovation is creating opportunities for manufacturers to develop lighter, more comfortable, and ergonomically designed supports.
Procedural treatments form another part of the market. These include injections, shockwave therapy, and surgical procedures for selected patients. However, surgical treatment generally represents a smaller portion of the treatment pathway, with conservative management frequently used before surgery. A population-based study found that only 4% of its tennis-elbow cohort underwent surgical intervention, while physical therapy and injections were substantially more common.
Which companies are prominent?
The competitive landscape includes Zimmer Biomet Holdings, Inc., MTS Medication Technologies, Breg, Inc., Össur hf, Medtronic plc, DePuy Synthes (Johnson & Johnson), Bioventus Inc., Stryker Corporation, Orthofix Medical Inc., and DJO Global, Inc.
These companies compete across orthopedic devices, rehabilitation products, bracing and support systems, surgical technologies, and treatment solutions. Product innovation, clinical usability, patient comfort, rehabilitation outcomes, and integration with orthopedic care pathways are increasingly important areas of competition.
Orthopedic and rehabilitation companies are also expanding their portfolios to address conservative treatment requirements. Bracing and support technologies can provide opportunities for companies to serve patients who are seeking non-invasive treatment options, while surgical and procedural technology providers address more persistent or refractory cases.
The competitive landscape reflects the broader evolution of tennis elbow care from conventional symptom management toward multimodal treatment and rehabilitation strategies. The company list represents prominent participants identified for the market rather than a revenue-ranked market-share table.
What is changing in 2026?
The tennis elbow treatment market is shifting toward conservative, personalized, and technology-supported care. Healthcare providers are increasingly emphasizing rehabilitation and non-invasive management before considering surgical intervention, particularly for patients who can respond to exercise-based therapy and other conservative approaches.
At the same time, treatment options are becoming more diverse. Shockwave therapy, platelet-rich plasma procedures, advanced bracing, and minimally invasive techniques are expanding the range of interventions available to patients with persistent symptoms. Market research indicates increasing interest in these approaches as healthcare providers seek alternatives to conventional treatment pathways.
Clinical evidence is also influencing treatment decisions. For example, research examining corticosteroid injection use found that its utilization for lateral epicondylitis declined from 2010 to 2017, while the number of injections among patients who received them increased. The researchers noted that this trend may reflect growing evidence concerning the limitations of corticosteroid injections for long-term outcomes.
Digital rehabilitation and biomechanical monitoring are emerging areas of interest. Physical therapy providers can increasingly use digital tools and movement assessment technologies to monitor rehabilitation progress and tailor exercise programs. These developments could support more personalized treatment while creating opportunities for connected orthopedic and rehabilitation products.
Purchase a Copy of this report: https://www.theinsightpartners.com/buy/TIPRE00040052
What are the major investment opportunities?
The major opportunities in the tennis elbow treatment market lie in non-invasive therapies, advanced orthopedic supports, rehabilitation technologies, minimally invasive procedures, and digital treatment platforms.
Investment in advanced bracing and support systems can address demand for products that provide targeted support while maintaining comfort and mobility. Manufacturers that improve ergonomics, materials, adjustability, and patient adherence can expand the role of braces within conservative treatment pathways.
Physical therapy and digital rehabilitation represent another significant opportunity. Technologies that enable therapists and patients to monitor movement, track exercise performance, and evaluate recovery could support the expansion of technology-enabled rehabilitation services.
There is also potential in shockwave therapy, biologic approaches, and minimally invasive procedures for patients whose symptoms persist despite conservative management. Research and development in these areas can create opportunities for medical-device and therapeutic companies, although clinical evidence, regulatory requirements, and reimbursement considerations remain important factors.
Related Reports:
Joint Replacement Devices Market Size & Growth Drivers 2031
Hip Implants Market Size, Share & Demand by 2034
About Us
The Insight Partners is a one-stop provider of actionable industry research and intelligence. We help our clients get solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Healthcare IT, Manufacturing and Construction, Medical Devices, Technology, Media and Telecommunications, Food and Beverages, Consumer Goods, and Chemicals and Materials.
Contact Us
Contact Person: Ankit Mathur
Phone: +1-646-491-9876
E-mail : sales@theinsightpartners.com
